Novel autophagy inhibitor ESK981 potentiates MEK inhibition cytotoxicity in pancreatic cancer

被引：0
|
作者：
Cheng, Caleb
Wisniewski, Jasmine
Jackson, Bailey
Bao, Yi
Qiao, Yuanyuan
Lyssiotis, Costas A.
Chinnaiyan, Arul M.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1634
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1634
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Enhancing the effect of autophagy inhibition for pancreatic cancer treatment
    Bryant, Kirsten L.
    Klomp, Jennifer E.
    Lee, Ye S.
    Stalnecker, Clint A.
    Grover, Kajal R.
    Edwards, A. Cole
    Peng, Sen
    Pierobon, Mariaelena
    Petricoin, Emanuel F., III
    Nhan Tran
    Kimmelman, Alec C.
    Cox, Adrienne D.
    Der, Channing J.
    CANCER RESEARCH, 2019, 79 (24)
  • [32] Radiosensitizing Pancreatic Cancer via Effective Autophagy Inhibition
    Yazal, Taha
    Bailleul, Justine
    Ruan, Yangjingyi
    Sung, David
    Chu, Fang-, I
    Palomera, Daisy
    Dao, Amy
    Sehgal, Anahita
    Gurunathan, Vibha
    Aryan, Laila
    Eghbali, Mansoureh
    Vlashi, Erina
    MOLECULAR CANCER THERAPEUTICS, 2022, 21 (01) : 79 - 88
  • [33] Chidamide, a novel histone deacetylase inhibitor, synergistically enhances gemcitabine cytotoxicity in pancreatic cancer cells
    Qiao, Zhixin
    Ren, Suping
    Li, Weijing
    Wang, Xuanlin
    He, Min
    Guo, Yingjie
    Sun, Liwei
    He, Yuezhong
    Ge, Yubin
    Yu, Qun
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 434 (01) : 95 - 101
  • [34] Dual inhibition of REV-ERBβ and autophagy as a novel pharmacological approach to induce cytotoxicity in cancer cells
    De Mei, C.
    Ercolani, L.
    Parodi, C.
    Veronesi, M.
    Lo Vecchio, C.
    Bottegoni, G.
    Torrente, E.
    Scarpelli, R.
    Marotta, R.
    Ruffili, R.
    Mattioli, M.
    Reggiani, A.
    Wade, M.
    Grimaldi, B.
    ONCOGENE, 2015, 34 (20) : 2597 - 2608
  • [35] Dual inhibition of REV-ERBβ and autophagy as a novel pharmacological approach to induce cytotoxicity in cancer cells
    C De Mei
    L Ercolani
    C Parodi
    M Veronesi
    C Lo Vecchio
    G Bottegoni
    E Torrente
    R Scarpelli
    R Marotta
    R Ruffili
    M Mattioli
    A Reggiani
    M Wade
    B Grimaldi
    Oncogene, 2015, 34 : 2597 - 2608
  • [36] Simultaneous Inhibition of MEK and Hh Signaling Reduces Pancreatic Cancer Metastasis
    Gu, Dongsheng
    Lin, Hai
    Zhang, Xiaoli
    Fan, Qipeng
    Chen, Shaoxiong
    Shahda, Safi
    Liu, Yunlong
    Sun, Jie
    Xie, Jingwu
    CANCERS, 2018, 10 (11)
  • [37] Dual MEK and AKT inhibition suppresses pancreatic cancer growth and migration
    Jack, Jarrid
    Pierce, Alexandra
    Bye, Bailey
    Walsh, McKinnon
    Chalise, Prabhakar
    VanSaun, Michael N.
    CANCER RESEARCH, 2022, 82 (12)
  • [38] IDH1 Inhibition Potentiates Chemotherapy Efficacy in Pancreatic Cancer
    Zarei, Mehrdad
    Hajihassani, Omid
    Hue, Jonathan J.
    Loftus, Alexander W.
    Graor, Hallie J.
    Nakazzi, Faith
    Naji, Parnian
    Boutros, Christina S.
    Uppin, Vinayak
    Vaziri-Gohar, Ali
    Shalaby, Akram S.
    Asara, John M.
    Rothermel, Luke D.
    Brody, Jonathan R.
    Winter, Jordan M.
    CANCER RESEARCH, 2024, 84 (18) : 3072 - 3085
  • [39] ERRα suppression enhances the cytotoxicity of the MEK inhibitor trametinib against colon cancer cells
    Zhou, Sheng
    Xia, Hongwei
    Xu, Huanji
    Tang, Qiulin
    Nie, Yongzhan
    Gong, Qi Yong
    Bi, Feng
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
  • [40] Preclinical efficacy of combined MEK and Src inhibition: MEK inhibitor reverses resistance to Src inhibitor therapy in ovarian cancer cells
    Simpkins, Fiona
    Azzam, Diana
    Slingerland, Joyce M.
    CLINICAL CANCER RESEARCH, 2013, 19
12345